These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12942169)

  • 41. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N; Kimmoun A; Furmaniuk A; Hekalo Z; Maskali F; Poussier S; Marie PY; Levy B
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of fluid restriction on measures of circulatory efficacy in adults with septic shock.
    Hjortrup PB; Haase N; Wetterslev J; Lange T; Bundgaard H; Rasmussen BS; Dey N; Wilkman E; Christensen L; Lodahl D; Bestle M; Perner A
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):390-398. PubMed ID: 28150304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
    Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
    Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
    Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of Practice Changes in the Care of Patients with Septic Shock during the U.S. Norepinephrine Shortage.
    Wunsch H; Hua M; Walkey AJ; Rubenfeld G; Vail E; Gershengorn HB
    Ann Am Thorac Soc; 2018 Apr; 15(4):509-511. PubMed ID: 29537858
    [No Abstract]   [Full Text] [Related]  

  • 48. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early, Goal-Directed Resuscitation for Septic Shock.
    Manaktala S; Claypool SR
    N Engl J Med; 2015 Aug; 373(6):577. PubMed ID: 26244317
    [No Abstract]   [Full Text] [Related]  

  • 50. Early, Goal-Directed Resuscitation for Septic Shock.
    Priebe HJ
    N Engl J Med; 2015 Aug; 373(6):576-7. PubMed ID: 26244316
    [No Abstract]   [Full Text] [Related]  

  • 51. Early, Goal-Directed Resuscitation for Septic Shock.
    Auinger K; Maggiorini M
    N Engl J Med; 2015 Aug; 373(6):576. PubMed ID: 26244315
    [No Abstract]   [Full Text] [Related]  

  • 52. Early, Goal-Directed Resuscitation for Septic Shock.
    Mouncey PR; Power GS; Coats TJ
    N Engl J Med; 2015 Aug; 373(6):577-8. PubMed ID: 26244314
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin for septic shock unresponsive to noradrenaline.
    Yunge M; Petros A
    Arch Dis Child; 2000 May; 82(5):388-9. PubMed ID: 10799431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In septic shock, MAP targets of 80 to 85 mm Hg vs 65 to 70 mm Hg did not differ for 28-day mortality.
    Thompson BT
    Ann Intern Med; 2014 Jul; 161(2):JC7. PubMed ID: 25023273
    [No Abstract]   [Full Text] [Related]  

  • 55. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Carr AC; Shaw GM; Fowler AA; Natarajan R
    Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Possible induction to mistake in the dilution of noradrenaline].
    Taberner Bonastre P; García Muñoz S; Soriano Clemente A; Soler Company E
    Farm Hosp; 2013; 37(6):558-9. PubMed ID: 24256020
    [No Abstract]   [Full Text] [Related]  

  • 57. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate.
    Sato R; Duggal A; Sacha GL; Rudoni MA; Yataco AC; Khanna AK; Dugar S
    Chest; 2023 Jan; 163(1):148-151. PubMed ID: 35921884
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
    De Backer D; Creteur J; Silva E; Vincent JL
    Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.